246 related articles for article (PubMed ID: 32598020)
1. Low serum levels of meteorin-like/subfatin: an indicator of diabetes mellitus and insulin resistance?
Onalan E; Cavlı C; Dogan Y; Onalan E; Gozel N; Buran I; Yakar B; Donder E
Endokrynol Pol; 2020; 71(5):397-403. PubMed ID: 32598020
[TBL] [Abstract][Full Text] [Related]
2. Serum Levels of Meteorin-Like (Metrnl) Are Increased in Patients with Newly Diagnosed Type 2 Diabetes Mellitus and Are Associated with Insulin Resistance.
Wang K; Li F; Wang C; Deng Y; Cao Z; Cui Y; Xu K; Ln P; Sun Y
Med Sci Monit; 2019 Mar; 25():2337-2343. PubMed ID: 30928991
[TBL] [Abstract][Full Text] [Related]
3. Lower serum levels of Meteorin-like/Subfatin in patients with coronary artery disease and type 2 diabetes mellitus are negatively associated with insulin resistance and inflammatory cytokines.
Dadmanesh M; Aghajani H; Fadaei R; Ghorban K
PLoS One; 2018; 13(9):e0204180. PubMed ID: 30212581
[TBL] [Abstract][Full Text] [Related]
4. Association of low serum Meteorin like (Metrnl) concentrations with worsening of glucose tolerance, impaired endothelial function and atherosclerosis.
El-Ashmawy HM; Selim FO; Hosny TAM; Almassry HN
Diabetes Res Clin Pract; 2019 Apr; 150():57-63. PubMed ID: 30825562
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of subfatin in patients with type 2 diabetes mellitus and its association with vascular adhesion molecules.
Fadaei R; Dadmanesh M; Moradi N; Ahmadi R; Shokoohi Nahrkhalaji A; Aghajani H; Ghorban K
Arch Physiol Biochem; 2020 Oct; 126(4):335-340. PubMed ID: 30463448
[TBL] [Abstract][Full Text] [Related]
6. Circulating Meteorin-like Levels in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis.
Wu Q; Dan YL; He YS; Xiang K; Hu YQ; Zhao CN; Zhong X; Wang DG; Pan HF
Curr Pharm Des; 2020; 26(44):5732-5738. PubMed ID: 33030126
[TBL] [Abstract][Full Text] [Related]
7. Potential emerging roles of the novel adipokines adipolin/CTRP12 and meteorin-like/METRNL in obesity-osteoarthritis interplay.
Sobieh BH; Kassem DH; Zakaria ZM; El-Mesallamy HO
Cytokine; 2021 Feb; 138():155368. PubMed ID: 33248913
[TBL] [Abstract][Full Text] [Related]
8. Serum Metrnl Level is Correlated with Insulin Resistance, But Not with β-Cell Function in Type 2 Diabetics.
Wang C; Pan Y; Song J; Sun Y; Li H; Chen L; Hou X
Med Sci Monit; 2019 Nov; 25():8968-8974. PubMed ID: 31766048
[TBL] [Abstract][Full Text] [Related]
9. Exploration of meteorin-like peptide (metrnl) predictors in type 2 diabetic patients: the potential role of irisin, and other biochemical parameters.
Khajebishak Y; Faghfouri AH; Soleimani A; Madani S; Payahoo L
Horm Mol Biol Clin Investig; 2023 Jun; 44(2):127-135. PubMed ID: 36181729
[TBL] [Abstract][Full Text] [Related]
10. Two Important Players for Type 2 Diabetes Mellitus: Metrnl and Asprosin.
Timurkaan M; Timurkaan ES
Clin Lab; 2022 Sep; 68(9):. PubMed ID: 36125157
[TBL] [Abstract][Full Text] [Related]
11. Association of Meteorin-Like Hormone with insulin resistance and body composition in healthy Iranian adults.
Alizadeh H; Alizadeh A
Diabetes Metab Syndr; 2020; 14(5):881-885. PubMed ID: 32563939
[TBL] [Abstract][Full Text] [Related]
12. Correlation of serum Meteorin-like (Metrnl) level with type 2 diabetic peripheral neuropathy.
Yao C; Zhang H; Wang L; Li J
BMC Endocr Disord; 2024 Jun; 24(1):83. PubMed ID: 38849768
[TBL] [Abstract][Full Text] [Related]
13. Increased Expression of Meteorin-Like Hormone in Type 2 Diabetes and Obesity and Its Association with Irisin.
AlKhairi I; Cherian P; Abu-Farha M; Madhoun AA; Nizam R; Melhem M; Jamal M; Al-Sabah S; Ali H; Tuomilehto J; Al-Mulla F; Abubaker J
Cells; 2019 Oct; 8(10):. PubMed ID: 31635130
[TBL] [Abstract][Full Text] [Related]
14. Correlation of serum meteorin-like concentrations with diabetic nephropathy.
Wang R; Hu D; Zhao X; Hu W
Diabetes Res Clin Pract; 2020 Nov; 169():108443. PubMed ID: 32946852
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis of the relationship between serums metrnl-like protein/subfatin and risk of type 2 diabetes mellitus and coronary artery disease.
Ferns GA; Fekri K; Shahini Shams Abadi M; Banitalebi Dehkordi M; Arjmand MH
Arch Physiol Biochem; 2023 Oct; 129(5):1084-1090. PubMed ID: 33950769
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Two Commercial Enzyme-Linked Immunosorbent Assay Kits for the Detection of Human Circulating Metrnl.
Zheng SL; Li ZY; Zhang Z; Wang DS; Xu J; Miao CY
Chem Pharm Bull (Tokyo); 2018 Apr; 66(4):391-398. PubMed ID: 29398678
[TBL] [Abstract][Full Text] [Related]
17. Circulating levels of Meteorin-like protein in polycystic ovary syndrome: A case-control study.
Fouani FZ; Fadaei R; Moradi N; Zandieh Z; Ansaripour S; Yekaninejad MS; Vatannejad A; Mahmoudi M
PLoS One; 2020; 15(4):e0231943. PubMed ID: 32330176
[TBL] [Abstract][Full Text] [Related]
18. Meteorin-like Protein and Asprosin Levels in Children and Adolescents with Obesity and Their Relationship with Insulin Resistance and Metabolic Syndrome.
Moradi N; Fadaei R; Roozbehkia M; Nourbakhsh M; Nourbakhsh M; Razzaghy-Azar M; Larijani B
Lab Med; 2023 Sep; 54(5):457-463. PubMed ID: 36762837
[TBL] [Abstract][Full Text] [Related]
19. Circulating mesencephalic astrocyte-derived neurotrophic factor is increased in newly diagnosed prediabetic and diabetic patients, and is associated with insulin resistance.
Wu T; Zhang F; Yang Q; Zhang Y; Liu Q; Jiang W; Cao H; Li D; Xie S; Tong N; He J
Endocr J; 2017 Apr; 64(4):403-410. PubMed ID: 28216543
[TBL] [Abstract][Full Text] [Related]
20. Serum Meteorin-like protein levels decreased in patients newly diagnosed with type 2 diabetes.
Lee JH; Kang YE; Kim JM; Choung S; Joung KH; Kim HJ; Ku BJ
Diabetes Res Clin Pract; 2018 Jan; 135():7-10. PubMed ID: 29097285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
